These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33973839)

  • 41. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
    Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
    World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative prediction of intra-tumoral tertiary lymphoid structures based on CT in hepatocellular cancer.
    Li P; Liang Y; Zeng B; Yang G; Zhu C; Zhao K; Xu Z; Wang G; Han C; Ye H; Liu Z; Zhu Y; Liang C
    Eur J Radiol; 2022 Jun; 151():110309. PubMed ID: 35468444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
    Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
    Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
    Li X; Yao Q; Liu C; Wang J; Zhang H; Li S; Cai P
    J Hepatocell Carcinoma; 2022; 9():379-387. PubMed ID: 35547829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nomogram prediction of vessels encapsulating tumor clusters in small hepatocellular carcinoma ≤ 3 cm based on enhanced magnetic resonance imaging.
    Chen HL; He RL; Gu MT; Zhao XY; Song KR; Zou WJ; Jia NY; Liu WM
    World J Gastrointest Oncol; 2024 May; 16(5):1808-1820. PubMed ID: 38764811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
    Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
    Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Impact of Vessels that Encapsulate Tumor Cluster (VETC) in Patients who Underwent Liver Transplantation for Hepatocellular Carcinoma.
    Kawasaki J; Toshima T; Yoshizumi T; Itoh S; Mano Y; Wang H; Iseda N; Harada N; Oda Y; Mori M
    Ann Surg Oncol; 2021 Dec; 28(13):8186-8195. PubMed ID: 34091774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Park S; Joo I; Lee DH; Bae JS; Yoo J; Kim SW; Lee JM
    Radiology; 2020 Sep; 296(3):554-561. PubMed ID: 32692297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic impact of vessels encapsulating tumor clusters and macrotrabecular patterns in hepatocellular carcinoma.
    Akiba J; Nakayama M; Sadashima E; Kusano H; Kondo R; Mihara Y; Naito Y; Mizuochi S; Yano Y; Kinjo Y; Tsutsui K; Kondo K; Sakai H; Hisaka T; Nakashima O; Yano H
    Pathol Res Pract; 2022 Oct; 238():154084. PubMed ID: 36087415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
    Calderaro J; Meunier L; Nguyen CT; Boubaya M; Caruso S; Luciani A; Amaddeo G; Regnault H; Nault JC; Cohen J; Oberti F; Michalak S; Bouattour M; Vilgrain V; Pageaux GP; Ramos J; Barget N; Guiu B; Paradis V; Aubé C; Laurent A; Pawlotsky JM; Ganne-Carrié N; Zucman-Rossi J; Seror O; Ziol M
    Clin Cancer Res; 2019 Oct; 25(19):5859-5865. PubMed ID: 31358545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor angiogenesis-related parameters in multi-phase enhanced CT correlated with outcomes of hepatocellular carcinoma patients after radical hepatectomy.
    Gao SY; Tang L; Cui Y; Li XT; Zhang XY; Shan J; Sun YS; Zhang XP
    Eur J Surg Oncol; 2016 Apr; 42(4):538-44. PubMed ID: 26852106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma.
    Gong Q; Zhang Y; Wu T; Du Z; Zhang Y
    Quant Imaging Med Surg; 2023 Jul; 13(7):4633-4640. PubMed ID: 37456331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang M; Cao L; Wang Y; Huang H; Tian X; Lei J
    Clin Transl Oncol; 2024 Aug; 26(8):2037-2046. PubMed ID: 38523240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
    Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
    Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.